Trials / Completed
CompletedNCT01084044
Effects of Ulinastatin on Coagulation in High Risk Patients Undergoing Off Pump Coronary Artery Bypass Graft Surgery
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 80 (actual)
- Sponsor
- Yonsei University · Academic / Other
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
Ulinastatin reduce the amount of bleeding and fibrinolysis in high risk patients undergoing off-pump coronary bypass surgery (OPCAB).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ulinastatin, saline solution | the ulinastatin group receiving ulinastatin (300,000 unit after anesthesia induction and another 300,000 unit during Y- graft anastomosis, n = 40), the control group receiving the same volume of saline solution(n = 40) |
Timeline
- Start date
- 2010-01-01
- Primary completion
- 2011-05-01
- Completion
- 2011-05-01
- First posted
- 2010-03-10
- Last updated
- 2012-02-02
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT01084044. Inclusion in this directory is not an endorsement.